Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001104659-25-100138
Filing Date
2025-10-16
Accepted
2025-10-16 17:10:09
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 16839
2 EXHIBIT 99.1 tm2528906d1_ex99-1.htm EX-99.1 11967
  Complete submission text file 0001104659-25-100138.txt   30461
Mailing Address 830 BRICKELL PLAZA MIAMI FL 33131
Business Address 830 BRICKELL PLAZA MIAMI FL 33131 305-929-6851
CITADEL ADVISORS LLC (Filed by) CIK: 0001423053 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G

Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Subject) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-91764 | Film No.: 251398328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)